牛牛AI助理已提取核心訊息
On February 22, 2024, AbbVie Inc. successfully entered into an underwriting agreement with major financial institutions including Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc., and Citigroup Global Markets Inc. The agreement facilitated a public offering where AbbVie issued $15.0 billion in senior notes with varying maturities ranging from 2027 to 2064. The notes were registered under the Securities Act of 1933, as amended, and are unsecured and unsubordinated, ranking equally with AbbVie's other similar obligations. AbbVie intends to use the net proceeds from the notes to prepay a term loan, fund acquisitions, repay borrowings under its commercial paper program, cover fees and expenses related to these activities, and for general corporate purposes. The offering was made pursuant to a prospectus supplement filed with the SEC on February 26, 2024.
On February 22, 2024, AbbVie Inc. successfully entered into an underwriting agreement with major financial institutions including Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc., and Citigroup Global Markets Inc. The agreement facilitated a public offering where AbbVie issued $15.0 billion in senior notes with varying maturities ranging from 2027 to 2064. The notes were registered under the Securities Act of 1933, as amended, and are unsecured and unsubordinated, ranking equally with AbbVie's other similar obligations. AbbVie intends to use the net proceeds from the notes to prepay a term loan, fund acquisitions, repay borrowings under its commercial paper program, cover fees and expenses related to these activities, and for general corporate purposes. The offering was made pursuant to a prospectus supplement filed with the SEC on February 26, 2024.
2024年2月22日，艾伯維公司成功與包括摩根士丹利公司在內的主要金融機構簽訂了承保協議。有限責任公司、摩根大通證券有限責任公司、美銀證券公司和花旗集團環球市場公司該協議促進了公開募股，艾伯維發行了150億美元的優先票據，期限從2027年到2064年不等。這些票據是根據經修訂的1933年《證券法》註冊的，是無抵押和無次級票據的，與艾伯維的其他類似債務持平。艾伯維打算將票據的淨收益用於預付定期貸款、爲收購提供資金、償還其商業票據計劃下的借款、支付與這些活動相關的費用和開支以及一般公司用途。此次發行是根據2024年2月26日向美國證券交易委員會提交的招股說明書補充文件進行的。
2024年2月22日，艾伯維公司成功與包括摩根士丹利公司在內的主要金融機構簽訂了承保協議。有限責任公司、摩根大通證券有限責任公司、美銀證券公司和花旗集團環球市場公司該協議促進了公開募股，艾伯維發行了150億美元的優先票據，期限從2027年到2064年不等。這些票據是根據經修訂的1933年《證券法》註冊的，是無抵押和無次級票據的，與艾伯維的其他類似債務持平。艾伯維打算將票據的淨收益用於預付定期貸款、爲收購提供資金、償還其商業票據計劃下的借款、支付與這些活動相關的費用和開支以及一般公司用途。此次發行是根據2024年2月26日向美國證券交易委員會提交的招股說明書補充文件進行的。
有用
沒用
